Ookuma K, Sakata T, Fukagawa K, Yoshimatsu H, Kurokawa M, Machidori H, Fujimoto K
Department of Internal Medicine I, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Brain Res. 1993 Nov 19;628(1-2):235-42. doi: 10.1016/0006-8993(93)90960-u.
Using probes to manipulate hypothalamic neuronal histamine, we report here that changes in neuronal histamine modulate physiological feeding behavior in rats. Infusion of alpha-fluoromethylhistidine (FMH), a "suicide" inhibitor of histidine decarboxylase (HDC), into the third cerebroventricle induced feeding in the early light phase when the histamine synthesis was most accelerated. FMH at an optimum 2.24 mumol dose elicited feeding in 100% of rats. Treatment of FMH specifically and selectively decreased concentration of histamine without affecting concentrations of catecholamines in the hypothalamus. Immediately before the dark phase, when the histamine synthesis was normally lower, FMH infusion did not affect feeding-related parameters such as meal size, meal duration or latency to eat. Conversely, thioperamide, which facilitates both synthesis and release of neuronal histamine by blocking presynaptic autoinhibitory H3 receptors, significantly decreased food intake after infusion of a 100-nmol dose into the third cerebroventricle. The effect of thioperamide was abolished with i.p. injection of 26 mumol/kg chlorpheniramine, an H1antagonist. FMH at 224 nmol was microinfused bilaterally into the feeding-related nuclei in the hypothalamus. The ventromedial nucleus (VMH) and the paraventricular nucleus (PVN), but not the lateral hypothalamus, the dorsomedial hypothalamus or the preoptic anterior hypothalamus were identified as the active sites for the modulation. Neuronal histamine may convey suppressive signals of food intake through H1 receptors in the VMH and the PVN with diurnal fluctuation.
通过使用探针操纵下丘脑神经元组胺,我们在此报告,神经元组胺的变化可调节大鼠的生理性摄食行为。向第三脑室注入组氨酸脱羧酶(HDC)的“自杀性”抑制剂α-氟甲基组氨酸(FMH),在组胺合成加速最快的早期光照阶段会诱发摄食。2.24 μmol的最佳剂量FMH可使100%的大鼠出现摄食行为。FMH处理特异性且选择性地降低了组胺浓度,而不影响下丘脑儿茶酚胺的浓度。在黑暗期即将开始前,此时组胺合成通常较低,注入FMH不会影响与摄食相关的参数,如进食量、进食持续时间或进食潜伏期。相反,硫代哌啶通过阻断突触前自身抑制性H3受体促进神经元组胺的合成和释放,向第三脑室注入100 nmol剂量后可显著减少食物摄入量。腹腔注射26 μmol/kg的H1拮抗剂氯苯那敏可消除硫代哌啶的作用。将224 nmol的FMH双侧微量注入下丘脑与摄食相关的核团。腹内侧核(VMH)和室旁核(PVN),而非外侧下丘脑、背内侧下丘脑或视前区下丘脑被确定为调节的活性位点。神经元组胺可能通过VMH和PVN中的H1受体传递食物摄入的抑制信号,且具有昼夜波动。